Postoperative Care of the Lung-Transplant Patient

  • Wickii T. Vigneswaran
  • Sangeeta M. Bhorade


The early postoperative care in the management of the lung-transplant patient has significantly changed over the past two decades. The advances in donor preservation, improved surgical techniques, better understanding of immunosuppression and nosocomial infection along with multidisciplinary care have contributed to these changes. Although management of the lung-transplant patient is similar in many aspects to that of a critically ill postsurgical patient, care of some of these patients is challenging, and a multidisciplinary team familiar with their care makes a difference. With this approach, the postoperative mortality rate is kept below 10% and the morbidity is minimized in many centers. Preoperative recipient preparation plays a key role in postoperative management and cannot be taken lightly. There are no major randomized clinical trials to draw conclusions or provide guidelines; therefore, the recommendations are made from large-volume lung-transplant centers and personal experiences, as well as experiences with major thoracic surgical procedures. This chapter summarizes the early postoperative management of patients undergoing isolated lung transplantation.


Acute Rejection Lung Transplantation Calcineurin Inhibitor Mycophenolate Mofetil Bronchiolitis Obliterans Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Trulock EP, Edwards LB, Taylor DO, Boucek MM, Keck BM, Hertz MI. The registry of the International Society of Heart and Lung Transplantation. J Heart Lung Transplant. 2006;25:869–911.PubMedCrossRefGoogle Scholar
  2. 2.
    Orens JB, Estenne M, Arcosoy S, et al. Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. International Guidelines for selection of lung transplant candidates: 2006 update. A consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2006;25:745–755.PubMedCrossRefGoogle Scholar
  3. 3.
    Barbour KA, Blumenthal JA, Palmer SM. Psychosocial issues in the assessment and management of patients undergoing lung transplantation. Chest. 2006;129:1367–1374.PubMedCrossRefGoogle Scholar
  4. 4.
    Madill J, Maurer JR, De Hoyos A. A comparison of pre-operative and post-operative nutritional states of lung transplant recipients. Transplantation. 1993;56:347–350.PubMedCrossRefGoogle Scholar
  5. 5.
    Vigneswaran WT, Bhorade S, Wolfe M, Pelletiere K, Garrity ER. Clinical pathway following lung transplantation shortens hospital length of stay without affecting outcome. Int Surg. 2007;92:93–98.PubMedGoogle Scholar
  6. 6.
    Christie JD, Carby M, Bag R, Corris P, Hertz M, Weill D. Report of the ISHLT working group on Primary Graft Dysfunction Part II. Definition. A consensus statement of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 2005;24:1454–1467.PubMedCrossRefGoogle Scholar
  7. 7.
    Barr ML, Kawut SM, Whelan TP, et al. Report of the ISHLT working group on Primary Graft Dysfunction Part IV: Recipient related risk factors and markers. J Heart Lung Transplant. 2005;24:1468–1482.PubMedCrossRefGoogle Scholar
  8. 8.
    Shargall Y, Guenther G, Ahya VN, Ardehali A, Singhal A, Keshavjee S. Report of the ISHLT working group on Primary Graft Dysfunction Part VI: treatment. J Heart Lung Transplant. 2005;24:1489–1500.PubMedCrossRefGoogle Scholar
  9. 9.
    Myers BF, Sundt TM III, Henry S, et al. Selective use of extracorporeal membrane oxygenation is warranted after lung transplantation. J Thorac Cardiovasc Surg. 2000;120:631–636.Google Scholar
  10. 10.
    Zenati M, Pham SM, Keenan RJ, Griffith BP. Extracorporeal membrane oxygenation for lung transplant recipients with primary severe donor lung dysfunction. Transpl Int. 1996;9:227–230.PubMedCrossRefGoogle Scholar
  11. 11.
    Patel VS, Palmer SM, Messier RH, Davis RD. Clinical outcomes after coronary artery revascularization and lung transplantation. Ann Thorac Surg. 2003;75:372–377.PubMedCrossRefGoogle Scholar
  12. 12.
    Choong CK, Meyers BF, Guthrie TJ, Trulock EP, Patterson GA, Moazami N. Does the presence of preoperative mild or moderate coronary artery disease affect the outcome of lung transplantation? Ann Thorac Surg. 2006;82:1038–1042.PubMedCrossRefGoogle Scholar
  13. 13.
    Wiedemann HP, Wheeler AP, Bernard GR, et al. Comparison of two fluid management strategies in acute lung injury. N Engl J Med. 2006;15:2564–2575.Google Scholar
  14. 14.
    Nielsen TD, Bahnson T, Davis RD, Palmer SM. Atrial fibrillation after pulmonary transplant. Chest. 2004;126:496–500.PubMedCrossRefGoogle Scholar
  15. 15.
    Vigneswaran WT, Sakiyalak P, Bhorade SM, Bakhos M. Airway complications after isolated lung transplantation. In: Morris PJ, Tilney NL, editors. Transplantation reviews. USA: Elsevier; 2002. 16(2): p. 87–94.Google Scholar
  16. 16.
    Keenan RJ, Konishi H, Kawai A, et al. Clinical trial of tacrolimus versus cyclosporine in lung transplantation. Ann Thorac Surg. 1995;60:580–585.PubMedCrossRefGoogle Scholar
  17. 17.
    Zuckermann AH, Reichenspurner T, Birsan H, et al. Cyclosporin A versus tacrolimus in combination with mycophenolate mofetil and steroids as primary immunosuppression after lung transplantation: one-year results of a 2-center prospective randomized trial. J Thorac Cardiovasc Surg. 2003;125:891–900.PubMedCrossRefGoogle Scholar
  18. 18.
    Palmer SM, Baz MA, Sanders L, et al. Results of a randomized, prospective, multicenter trial of mycophenolate mofetil versus azathioprine in the prevention of acute lung allograft rejection. Transplantation. 2001;71:1772–1776.PubMedCrossRefGoogle Scholar
  19. 19.
    McNeil K, Glanville AR, Wahlers T, et al. Comparison of mycophenolate mofetil and azathioprine for prevention of bronchiolitis obliterans syndrome in de novo lung transplant recipients. Transplantation. 2006;81:998–1003.PubMedCrossRefGoogle Scholar
  20. 20.
    Beniaminovitz A, Itescu S, Lietz K, et al. Prevention of rejection in cardiac transplantation by blockade of the interleukin-2 receptor with a monoclonal antibody. N Engl J Med. 2000;342:613–619.PubMedCrossRefGoogle Scholar
  21. 21.
    Garrity ER Jr, Villanueva J, Bhorade SM, Husain AN, Vigneswaran WT. Low rate of acute lung allograft rejection after the use of daclizumab, an interleukin 2 receptor antibody. Transplantation. 2001;71:773–777.PubMedCrossRefGoogle Scholar
  22. 22.
    Brock MV, Borja MC, Ferber L, et al. Induction therapy in lung transplantation: a prospective, controlled clinical trial comparing OKT3, anti-thymocyte globulin, and daclizumab. J Heart Lung Transplant. 2001;20:1282–1290.PubMedCrossRefGoogle Scholar
  23. 23.
    Christie JD, Kotloff RM, Pochettino A, et al. Clinical risk factors for primary graft failure following lung transplantation. Chest. 2003;124:1232–1241.PubMedCrossRefGoogle Scholar
  24. 24.
    Chatila WM, Furukawa S, Gaughan JP, Criner GJ. Respiratory failure after lung transplantation. Chest. 2003;123:165–173.PubMedCrossRefGoogle Scholar
  25. 25.
    Kroshus TJ, Kshettry VR, Hertz MI, Bolman RM III. Deep venous thrombosis and pulmonary embolism after lung transplantation. J Thorac Cardiovasc Surg. 1995;110:540–544.PubMedCrossRefGoogle Scholar
  26. 26.
    Burns KE, Iacono AT. Pulmonary embolism on postmortem examination: an under-recognized complication in lung transplant recipients? Transplantation. 2004;77:692–698.PubMedCrossRefGoogle Scholar
  27. 27.
    Young LR, Hadjiliadis D, Davis RD, Palmer SM. Lung transplantation exacerbates gastroesophageal reflux disease. Chest. 2003;124:1689–1693.PubMedCrossRefGoogle Scholar
  28. 28.
    Davis RD Jr, Lau CL, Eubank S, et al. Improved lung allograft function after fundoplication in patients with gastroesophageal reflux disease undergoing lung transplantation. J Thorac Cardiovasc Surg. 2003;125:533–542.PubMedCrossRefGoogle Scholar
  29. 29.
    Goldstein LS, Haug MT, Perl J, et al. Central nervous system complications after lung transplantation. J Heart Lung Transplant. 1998;17:185–191.PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Wickii T. Vigneswaran
    • 1
  • Sangeeta M. Bhorade
    • 2
  1. 1.Department of Surgery, University of Chicago HospitalsUniversity of ChicagoChicagoUSA
  2. 2.Department of Medicine, University of Chicago HospitalsUniversity of ChicagoChicagoUSA

Personalised recommendations